(Q33418967)

English

Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, [...]

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25439694%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25439694%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

0 references

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25439694%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Oliver Sartor

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25439694%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Joe M O'Sullivan

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25439694%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Dag Clement Johannessen

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25439694%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Svein I Helle

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25439694%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

John Logue

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25439694%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

David Bottomley

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25439694%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Sten Nilsson

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25439694%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Nicholas J Vogelzang

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25439694%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Fang Fang

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25439694%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Mona Wahba

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25439694%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Anne-Kirsti Aksnes

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25439694%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Christopher Parker

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25439694%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

publication date

17 October 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25439694%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25439694%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25439694%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25439694%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1397-1406

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25439694%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970474-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970474-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Taxanes in the management of metastatic castration-resistant prostate cancer: efficacy and management of toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970474-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A population-based study of prostate cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970474-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970474-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970474-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Abiraterone and increased survival in metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970474-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Abiraterone in metastatic prostate cancer without previous chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970474-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased survival with enzalutamide in prostate cancer after chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970474-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Enzalutamide in metastatic prostate cancer before chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970474-7

7 January 2021

based on heuristic

inferred from DOI database lookup

High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223Ra: adjuvant or alternative to conventional modalities?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970474-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Alpha emitter radium-223 and survival in metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970474-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970474-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(14)70474-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25439694%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25439694%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33418967&oldid=1577734572"